DVA Stock Analysis: Buy, Sell, or Hold?
DVA - DaVita Inc.
$192.58
-5.52 (-2.79%)
▼
5d:
-1.88%
30d:
+33.21%
90d:
+28.41%
BUY
MODERATE Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 05, 2026
0d
Smart Money Accumulation
None View Scanner →
Strength: 3.6/10
Get Alerted When DVA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called DVA this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: DVA shows positive signals but monitor for confirmation. Market pricing in 6.6% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: DVA shows positive signals but monitor for confirmation. Market pricing in 6.6% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$256.95
Based on 10.1% avg growth
INTRINSIC VALUE TODAY
$159.55
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: DVA is currently trading at $192.58, which is considered extended relative to its 30-day fair value range of $142.08 to $181.92. From a valuation perspective, the stock is trading at a premium (Forward PE: 11.2) compared to its historical average (9.3). At these levels, the market is pricing in 6.6% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, DVA is in a strong uptrend. Immediate support is located at $148.00, while resistance sits at $202.69.
Market Sentiment: DVA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, DVA is in a strong uptrend. Immediate support is located at $148.00, while resistance sits at $202.69.
Market Sentiment: DVA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$142.08 -
$181.92
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
60.8%
Protect Your Profits
DVA is technically overbought (RSI 72). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+5.9% above its trading range)
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($193.71)
- NEUTRAL: Trading at premium valuation - market expects 6.6% growth which is achievable
Trading Range Analysis
30-Day Trading Range
$142.08 -
$181.92
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$8.49
(4.4%)
Support & Resistance Levels
Support Level
$148.00
Resistance Level
$202.69
Current Trend
Strong Uptrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
11.21
Wall Street Target
$193.71
(+0.6%)
Revenue Growth (YoY)
6.0%
Earnings Growth (YoY)
43.5%
Profit Margin
5.7%
Valuation Premium vs History
+6.6% premium
PE vs Historical
11.2 vs 9.3
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.6%
(market-implied from PE analysis)
1-Year Target
$205.29
(+7%)
2-Year Target
$218.84
(+14%)
3-Year Target
$233.28
(+21%)
3-Yr Target (if PE normalizes)
(PE: 11→9)
PE COMPRESSION
$193.56
(+1%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.0, Growth: 16.1%)
$592.74
(+208%)
Base:
(SPY PE: 11.2, Growth: 16.1%)
$301.44
(+57%)
Bear:
(PE: 9.3, Growth: 16.1%)
$250.11
(+30%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (19x PE), but valuation improves significantly next year (11x PE) as earnings recover.
Trailing PE: 19.08 | Current EPS (TTM): $10.38
Bull Case
$360.70
(+87%)
Analyst growth 65.5%, PE expands to 21.0
Base Case
$327.91
(+70%)
Market implied 65.5%, PE stable at 19.1
Bear Case
$134.71
(-30%)
Severe decline -20.0%, PE contracts to 16.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: May 14, 2026 11:35 PM ET
Data refreshes hourly during market hours. Next update: 12:35 AM
Data refreshes hourly during market hours. Next update: 12:35 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DVA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Featured in Portfolios
DVA is a key holding in these high-performance investment strategies.
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HCA
HCA Holdings Inc |
BUY
25 analysts |
$513 | 66 BUY |
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$246 | 59 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 62 BUY |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$21 | 63 BUY |
|
CON
Concentra Group Holdings… |
STRONG BUY
8 analysts |
$30 | 62 BUY |
Advanced DVA Option Strategies
Professional options setups generated by AI based on today's DVA price and gamma walls.
